ID   RCC-26/CD80/IL-7
AC   CVCL_C3HN
DR   Wikidata; Q114312776
RX   PubMed=15755994;
RX   PubMed=15997395;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6023; IL7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ70 ! RCC-26
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
RX   PubMed=15755994; DOI=10.1158/1078-0432.CCR-04-1883;
RA   Frankenberger B., Pohla H., Noessner E., Willimsky G., Papier B.,
RA   Pezzutto A., Kopp J., Oberneder R., Blankenstein T., Schendel D.J.;
RT   "Influence of CD80, interleukin-2, and interleukin-7 expression in
RT   human renal cell carcinoma on the expansion, function, and survival of
RT   tumor-specific CTLs.";
RL   Clin. Cancer Res. 11:1733-1742(2005).
//
RX   PubMed=15997395; DOI=10.1007/s00345-005-0505-5;
RA   Frankenberger B., Regn S., Geiger C., Noessner E., Falk C.S.,
RA   Pohla H., Javorovic M., Silberzahn T., Wilde S., Buchner A.,
RA   Siebels M., Oberneder R., Willimsky G., Pezzutto A., Blankenstein T.,
RA   Schendel D.J.;
RT   "Cell-based vaccines for renal cell carcinoma: genetically-engineered
RT   tumor cells and monocyte-derived dendritic cells.";
RL   World J. Urol. 23:166-174(2005).
//